subject: CHEBI:95165

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA Breast Carcinoma

tested_intervention: unsure


subject: CHEBI:95165

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:95165

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:95165

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:95165

object_name: triple-negative breast carcinoma


subject: CHEBI:95165

object_name: Progesterone Receptor Negative


subject: CHEBI:95165

object_name: invasive breast carcinoma


subject: CHEBI:95165

object_name: HER2/Neu Negative


subject: CHEBI:95165

object_name: breast adenocarcinoma


subject: CHEBI:50131

subject_name: Decitabine

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:50131

object_name: Progesterone receptor positive tumor


subject: CHEBI:50131

object_name: Breast cancer stage II


subject: CHEBI:50131

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:50131

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:50131

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:50131

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:50131

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:50131

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:50131

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:50131

object_name: triple-negative breast carcinoma


subject: CHEBI:50131

object_name: Progesterone Receptor Negative


subject: CHEBI:50131

object_name: invasive breast carcinoma


subject: CHEBI:50131

object_name: HER2/Neu Negative


subject: CHEBI:50131

object_name: breast adenocarcinoma


subject: CHEBI:64816

object_name: Progesterone receptor positive tumor


subject: CHEBI:64816

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: estrogen-receptor positive breast cancer


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIB Breast Carcinoma


subject: UNII:DPT0O3T46P

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:31515

subject_name: Domperidone

object_name: Parkinson disease

tested_intervention: yes


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: sinus histiocytosis with massive lymphadenopathy


subject: CHEBI:168396

object_name: Langerhans cell histiocytosis


subject: CHEBI:168396

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:168396

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Mismatch Repair Protein Proficient


subject: CHEBI:31348


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423

object_name: Locally Advanced Rectal Carcinoma


subject: CHEBI:41423

object_name: Marinesco-Sjogren syndrome


subject: CHEBI:41423

object_name: Microsatellite Stable


subject: CHEBI:41423


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C0385862

object_name: dysplasia of cervix


subject: UMLS:C0385862

object_name: cervical intraepithelial neoplasia


subject: UMLS:C2933824

object_name: liver failure


subject: CHEBI:82977

subject_name: Daclatasvir


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: urinary bladder carcinoma


subject: GTOPDB:9592

object_name: urinary bladder cancer


subject: GTOPDB:9592

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: bladder tumor


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:231087


subject: UNII:FBK9G669EY

subject_name: CHO CELL

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: MESH:C000634150

object_name: asthma


subject: UMLS:C1520059

subject_name: Vitamin D Analog

object_name: secondary hyperparathyroidism


subject: UMLS:C2917444

subject_name: Vitamin D Analog [EPC]


subject: UMLS:C4526708

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C4526708


subject: UMLS:C4526708

object_name: Childhood Solid Neoplasm


subject: UMLS:C4526708

object_name: Adult Solid Neoplasm


subject: UMLS:C4526708

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:133081958

object_name: Mismatch Repair Protein Proficient


subject: PUBCHEM.COMPOUND:133081958

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:133081958

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:133081958


subject: CHEBI:20551

object_name: inflammatory bowel disease


subject: CHEBI:20551

object_name: Crohn disease


subject: CHEBI:20551

object_name: ulcerative colitis


subject: CHEBI:20551

object_name: inflammatory bowel disease 1


subject: UMLS:C0098148


subject: UMLS:C0098148


subject: UMLS:C0098148


subject: UMLS:C0098148


subject: UMLS:C0678171

subject_name: Pentasa


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Relapsing acute myeloid leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: Malignant myeloproliferative neoplasm


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: primary disorders


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Local anesthetic agent poisoning


subject: CHEBI:60802

object_name: Poisoning by, adverse effect of and underdosing of local anesthetics


subject: CHEBI:60802

object_name: Local anaesthetics causing adverse effects in therapeutic use


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: ichthyosis


subject: PUBCHEM.COMPOUND:3467

object_name: inherited ichthyosis


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: liver carcinoma


subject: CHEBI:94366

subject_name: itraconazole

object_name: impotence


subject: CHEBI:94366

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:94366

object_name: Erectile dysfunction


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Ischemic stroke


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:23965

subject_name: estradiol

object_name: luminal A breast carcinoma


subject: CHEBI:23965

object_name: breast lobular carcinoma


subject: CHEBI:23965

object_name: Axillary lymphadenopathy


subject: CHEBI:77572

subject_name: Tranilast

object_name: rheumatoid arthritis


subject: CHEBI:135207

subject_name: Clofedanol

object_name: pneumonia


subject: CHEBI:135207

object_name: Acute pneumonia


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:75551


subject: CHEBI:75551


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Adult Acute Myeloid Leukemia in Remission


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3081837

subject_name: Flammacerium

object_name: Burn injury


subject: UMLS:C0244799


subject: CHEBI:9142

subject_name: Silver sulfadiazine


subject: UMLS:C0729114

subject_name: Flamazine


subject: UMLS:C2830204

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3827097

object_name: amyloidosis


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Emergence Delirium


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C0879396

object_name: Stomach cancer


subject: UMLS:C0879396

object_name: gastric cancer


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:59905

object_name: diastolic heart failure


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: variegate porphyria


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: spinal cord disorder


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:70752

subject_name: Dabigatran

object_name: Left atrial appendage thrombosis


subject: PUBCHEM.COMPOUND:66621102

object_name: HIV-1 infection


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Adverse effects


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)

object_name: non-small cell lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: brain injury


subject: CHEBI:35341

subject_name: steroid

object_name: nasopharyngeal carcinoma


subject: CHEBI:35341

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:35341


subject: CHEBI:35341

object_name: Adverse effect of radiation therapy


subject: CHEBI:35341

object_name: Disorder due to radiotherapy


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: CHEBI:85980

subject_name: Eluxadoline

object_name: Bowel incontinence


subject: CHEBI:85980

object_name: Fecal Incontinence, CTCAE


subject: CHEBI:85980

object_name: urgency urinary incontinence


subject: CHEBI:85980

object_name: diarrhea


subject: CHEBI:85980

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:85980

object_name: Diarrhea, CTCAE


subject: CHEBI:58097

object_name: Consent Type - Hysterectomy


subject: CHEBI:58097

object_name: myoma


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: UNII:O9BP19HZ3Q

object_name: panic disorder


subject: UNII:O9BP19HZ3Q

object_name: panic disorder 1


subject: DRUGBANK:DB18966

subject_name: Darigabat


subject: DRUGBANK:DB18966


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: ovarian cancer


subject: UMLS:C3898831

object_name: ovarian neoplasm


subject: UMLS:C3898831

object_name: ovarian carcinoma


subject: CHEBI:151315

subject_name: Heparin

object_name: Decompensated cirrhosis of liver


subject: CHEBI:151315

object_name: Acute-On-Chronic Liver Failure


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Androgen excess


subject: CHEBI:17650

object_name: Increased circulating androgen concentration


subject: UNII:6D848RA61B

subject_name: Somatrogon

object_name: pituitary dwarfism


subject: UMLS:C0742795

subject_name: contrast dye

object_name: Childhood Breast Carcinoma


subject: UMLS:C0742795

object_name: breast carcinoma


subject: UMLS:C0742795

object_name: breast cancer


subject: UMLS:C3273946

subject_name: Anti-c-fms Monoclonal Antibody AMG 820

object_name: neoplasm


subject: UMLS:C3273946

object_name: cancer


subject: UNII:KNM216XOUH

object_name: anxiety


subject: UNII:KNM216XOUH

object_name: Anxiety symptoms


subject: UNII:KNM216XOUH

object_name: Anxiety, CTCAE 3.0


subject: UNII:KNM216XOUH

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C3500879


subject: UMLS:C3500879


subject: UMLS:C3500879


subject: UMLS:C3500879


subject: UMLS:C0599278

subject_name: radioligand


subject: UMLS:C0599278

object_name: anxiety disorder


subject: UMLS:C0599278


subject: UMLS:C0599278


subject: UMLS:C0599278


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Menopause present (finding)


subject: CHEBI:36791

object_name: Menopause


subject: CHEBI:36791

object_name: vasomotor symptom


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: UNII:J303A6U9Y6

subject_name: ENCLOMIPHENE CITRATE

object_name: infertility


subject: UMLS:C0086214

subject_name: Enclomiphene Citrate


subject: PUBCHEM.COMPOUND:118676295

subject_name: vicadrostat

object_name: heart failure


subject: PUBCHEM.COMPOUND:118676295

object_name: Heart Failure, CTCAE


subject: UNII:AF4VW4GA3H

subject_name: VICADROSTAT


subject: UNII:AF4VW4GA3H


subject: CHEBI:30879

subject_name: alcohol

object_name: Inflammation


subject: CHEBI:16236

subject_name: Ethanol


subject: UMLS:C3641863

object_name: cholangiocarcinoma


subject: CHEBI:149504

object_name: Serious mental illness


subject: CHEBI:149504

object_name: schizoaffective disorder


subject: CHEBI:149504

object_name: schizophrenia 18


subject: CHEBI:149504

object_name: schizophrenia


subject: CHEBI:149504

object_name: endogenous depression


subject: CHEBI:149504

object_name: major depressive disorder


subject: CHEBI:149504

object_name: bipolar disorder


subject: CHEBI:149504

object_name: psychosis


subject: CHEBI:149504

object_name: Nonorganic psychosis


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:9150

subject_name: Simvastatin


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: chronic rhinosinusitis with nasal polyps


subject: CHEBI:72296

subject_name: Apixaban

object_name: aortic valve; failure


subject: CHEBI:72296

object_name: aortic valve disease 2


subject: CHEBI:72296

object_name: aortic valve disease 3


subject: CHEBI:72296

object_name: Stenosis of aorta


subject: CHEBI:145796

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:3061

subject_name: Digimed


subject: CHEBI:28544

subject_name: Digitoxin


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Recurrent Ovarian Germ Cell Tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: undifferentiated ovarian carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: ovarian seromucinous carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: ovarian serous cystadenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: ovarian endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: ovarian serous surface papillary adenocarcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UMLS:C0388088

object_name: primary progressive multiple sclerosis


subject: CHEBI:63115

subject_name: Fingolimod


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C3652932

subject_name: pyronaridine and artesunate drug combination

object_name: Malaria, antepartum


subject: CHEBI:32019

subject_name: Piromidic acid

object_name: Uncomplicated malaria


subject: CHEBI:32019


subject: CHEBI:133659

subject_name: Pro-Ala


subject: CHEBI:133659


subject: CHEBI:33386

subject_name: Protactinium


subject: CHEBI:33386


subject: CHEBI:30745

subject_name: Phenylacetic acid


subject: CHEBI:30745


subject: CHEBI:8428

subject_name: Procainamide


subject: CHEBI:8428


subject: CHEBI:7959

subject_name: Penicillamine


subject: CHEBI:7959


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:16335


subject: CHEBI:30768

subject_name: Propanoic acid


subject: CHEBI:30768


subject: PR:000049747

subject_name: influenzavirus PA gene translation product


subject: PR:000049747


subject: PR:000004008

subject_name: alpha-amylase 2A


subject: PR:000004008


subject: PR:000012849

subject_name: biogenesis of lysosome-related organelles complex 1 subunit 6


subject: PR:000012849


subject: PR:000013209

subject_name: salivary acidic proline-rich phosphoprotein


subject: PR:000013209


subject: CHEBI:137245

subject_name: Asp-Pro


subject: CHEBI:137245


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:4653


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: glioma


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L

object_name: malignant glioma


subject: CHEBI:135207

subject_name: Clofedanol

object_name: respiratory failure


subject: CHEBI:135207

object_name: Respiratory Failure, CTCAE


subject: CHEBI:135207

object_name: viral pneumonia


subject: CHEBI:135207

object_name: Coronavinae infectious disease


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:37941

object_name: Thromboembolism


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX


subject: PUBCHEM.COMPOUND:52943456


subject: PUBCHEM.COMPOUND:52943456


subject: PUBCHEM.COMPOUND:52943456


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:9605

subject_name: Tirofiban


subject: CHEBI:9605


subject: CHEBI:9605


subject: CHEBI:9605


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: liver cancer


subject: CHEBI:41774

object_name: liver neoplasm


subject: CHEBI:41774

object_name: Adult Liver Carcinoma


subject: CHEBI:41774

object_name: liver carcinoma


subject: UMLS:C0600472

subject_name: Long Interspersed Nucleotide Element-1

object_name: Stomach cancer


subject: UMLS:C0600472

object_name: gastric cancer


subject: UMLS:C0600472

object_name: carcinoma of esophagus


subject: UMLS:C0600472

object_name: esophageal cancer


subject: UMLS:C0600472

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0600472

object_name: neoplasm of esophagus


subject: UMLS:C0600472


subject: UMLS:C0600472


subject: UMLS:C0600472


subject: UMLS:C0600472


subject: UniProtKB:P03101

subject_name: VL1_HPV16 Major capsid protein L1 (sprot)


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:Q07860

subject_name: VL1_HPV04 Major capsid protein L1 (sprot)


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: PR:000029475

subject_name: CYFIP-related Rac1 interactor B


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: UMLS:C2934919

object_name: type 2 diabetes mellitus


subject: UMLS:C2934919

object_name: Diabetes


subject: UMLS:C2934919

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: nicotine dependence


subject: CHEBI:64356

subject_name: Pregabalin


subject: PUBCHEM.COMPOUND:146599824

object_name: atopic eczema


subject: UNII:2SXR65P7E3


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Abnormal gastric motility


subject: UNII:Q830PW7520

subject_name: CODEINE


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: PUBCHEM.COMPOUND:54736666

subject_name: Triumeq

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:54736666

object_name: amyotrophic lateral sclerosis


subject: RXCUI:1546884

subject_name: abacavir / dolutegravir / lamivudine Oral Product


subject: RXCUI:1546884


subject: UMLS:C5815510

object_name: Bloody diarrhea


subject: UMLS:C5815510

object_name: Shiga toxin-producing Escherichia coli [E. coli] (STEC), unspecified


subject: CHEBI:23965

subject_name: estradiol

object_name: Breastfeeding (mother)


subject: CHEBI:23965

object_name: postpartum sexual dysfunction


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Complication of ventilation therapy


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:41774

object_name: pancreatic mucinous cystadenoma


subject: CHEBI:41774

object_name: pancreatic mucinous-cystic neoplasm


subject: CHEBI:41774

object_name: Pancreatic Cyst


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:11227182

object_name: Acute Kidney Injury, CTCAE


subject: UNII:A2VM2V569A

object_name: melanoma


subject: HMDB:HMDB0014612

subject_name: Tenoxicam

object_name: pain agnosia


subject: HMDB:HMDB0014612

object_name: Pain insensitivity


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: opioid use


subject: CHEBI:36939

object_name: HIV infection


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Interstitial pneumonitis


subject: UMLS:C2830067

object_name: fibromatosis


subject: UMLS:C2830067

object_name: desmoid tumor


subject: UMLS:C2830067

object_name: Desmoid tumor


subject: CHEBI:44915

subject_name: Propofol

object_name: breast neoplasm


subject: CHEBI:44915

object_name: rectal neoplasm


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130

object_name: Colon Neoplasm


subject: CHEBI:71952

subject_name: Dactolisib

object_name: renal carcinoma


subject: CHEBI:71952

object_name: kidney cancer


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C0003442

object_name: bone marrow failure syndrome


subject: UMLS:C0003442

object_name: T-cell lymphoma recurrent


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:167450


subject: CHEBI:167450

object_name: marginal zone lymphoma


subject: CHEBI:167450

object_name: MALT lymphoma


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:9168

object_name: follicular lymphoma


subject: UMLS:C2981359

subject_name: fezakinumab

object_name: atopic eczema


subject: UNII:8S38482CST

object_name: hepatitis C


subject: UNII:8S38482CST

object_name: chronic hepatitis C virus infection


subject: UMLS:C3274627

subject_name: Synbiotic Supplement

object_name: body composition measurement


subject: CHEBI:139306

subject_name: methanol extract of Sorbus alnifolia

object_name: Lymphoma, Extranodal NK-T-Cell


subject: CHEBI:7772

subject_name: omeprazole

object_name: Clostridium difficile colitis


subject: CHEBI:7772

object_name: clostridium difficile infection


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UMLS:C1382107

subject_name: Suspension substance


subject: UMLS:C1382107


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Inflammation


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Low back pain


subject: CHEBI:52717

subject_name: Bortezomib

object_name: carcinoma of esophagus


subject: CHEBI:52717

object_name: esophageal cancer


subject: CHEBI:52717

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:52717

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL5315015

object_name: xerophthalmia


subject: CHEMBL.COMPOUND:CHEMBL5315015

object_name: dry eye syndrome


subject: CHEMBL.COMPOUND:CHEMBL5315015

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C5853361


subject: UMLS:C5853361


subject: UMLS:C5853361


subject: UMLS:C5783890

subject_name: Anti-KLRG1 Monoclonal Antibody ABC008

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C1512628

subject_name: Medicinal product acting as imaging agent (product)

object_name: Stage I Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C1512628

object_name: Stage II Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C1512628

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C1512628

object_name: squamous cell carcinoma of floor of mouth


subject: UMLS:C1512628

object_name: Retromolar Trigone Squamous Cell Carcinoma


subject: UMLS:C1512628

object_name: Lower Alveolar Ridge Squamous Cell Carcinoma


subject: UMLS:C1512628

object_name: Upper Alveolar Ridge Squamous Cell Carcinoma


subject: UMLS:C1512628

object_name: Gingival Squamous Cell Carcinoma


subject: UMLS:C1512628

object_name: Hard Palate Squamous Cell Carcinoma


subject: UMLS:C1512628

object_name: squamous cell carcinoma of buccal mucosa


subject: UMLS:C1512628

object_name: tongue squamous cell carcinoma


subject: UMLS:C1512628

object_name: squamous cell carcinoma of lip


subject: UMLS:C5399731

subject_name: Imaging Agent [APC]


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C5399731


subject: UMLS:C2348174

object_name: prostate carcinoma


subject: UMLS:C2348174

object_name: prostate cancer


subject: UMLS:C2348174

object_name: prostate neoplasm


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: small cell lung carcinoma


subject: CHEBI:6503

object_name: non-small cell lung carcinoma


subject: CHEBI:6503

object_name: Dyspnea


subject: CHEBI:6503

object_name: Dyspnea, CTCAE


subject: CHEBI:6503

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:43755


subject: MESH:C000723127

subject_name: Aventis Pasteur smallpox vaccine

object_name: smallpox


subject: UMLS:C0733796

subject_name: Gastrografin

object_name: Adhesive small bowel obstruction


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: perinatal asphyxia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Perinatal depression in mother


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: CHEBI:8382

subject_name: Prednisone

object_name: Stage IIC Prostate Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: UMLS:C4042170

object_name: adult lymphoma


subject: UMLS:C4042170

object_name: lymphoma


subject: UMLS:C4042170

object_name: pediatric lymphoma


subject: UMLS:C0059079

subject_name: EMLA

object_name: Neck Carcinoma


subject: UMLS:C0059079

object_name: head and neck neoplasm


subject: UMLS:C0059079

object_name: head and neck cancer


subject: UMLS:C0059079

object_name: skin neoplasm


subject: UMLS:C0059079

object_name: Acute Pain


subject: CHEBI:47554

subject_name: Ethyl chloride


subject: CHEBI:47554


subject: CHEBI:47554


subject: CHEBI:47554


subject: CHEBI:47554


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: cutis laxa


subject: CHEBI:51230

object_name: Dermatochalasis


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0812735

object_name: acute myeloid leukemia


subject: UMLS:C0812735

object_name: inherited disease susceptibility


subject: UMLS:C0812735

object_name: aspergillosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:147912

object_name: candidiasis


subject: CHEBI:143658

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:143658

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:143658

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:71223

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: actinic keratosis


subject: CHEBI:136034

object_name: squamous cell carcinoma


subject: UMLS:C0066889

subject_name: MT-I


subject: UMLS:C0066889


subject: CHEBI:49603

subject_name: Lapatinib

object_name: childhood malignant neoplasm


subject: CHEBI:49603

object_name: brain cancer


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Cancer of Neck


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT

object_name: Cancer of Head


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:31822

subject_name: MERCAPTOPURINE

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: glucose intolerance


subject: PUBCHEM.COMPOUND:57389748

object_name: Impaired glucose tolerance


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Labor Pain


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Adherence To Medication Regime


subject: UMLS:C0537895

object_name: Mycoses


subject: CHEBI:132082

subject_name: Entinostat

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:132082

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:132082

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:132082

object_name: Blast Phase


subject: CHEBI:132082

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:131769963

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C4301616

subject_name: fluoroestradiol (18F)

object_name: Breast cancer recurrent


subject: UMLS:C4301616

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4301616

object_name: Carcinoma breast stage IV


subject: UMLS:C4301616

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4301616

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5439626

subject_name: Fluoroestradiol f 18, diagnostic, 1 millicurie


subject: UMLS:C5439626


subject: UMLS:C5439626


subject: UMLS:C5439626


subject: UMLS:C5439626


subject: UMLS:C2987404

subject_name: Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05

object_name: leukemia


subject: UMLS:C2987404

object_name: childhood leukemia


subject: UNII:JA8K50N04H

subject_name: MYRCLUDEX B

object_name: chronic hepatitis D infection


subject: UMLS:C3491973

subject_name: myrcludex-B


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: end stage renal failure


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011

object_name: Chronic uremia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Chemotherapy-induced nausea and vomiting


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Hypothyroxinemia


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:27470

subject_name: Folic acid

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:27470

object_name: metabolic syndrome X


subject: CHEBI:24848

subject_name: inositol

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:24848

object_name: obesity


subject: CHEBI:24848

object_name: Obesity, CTCAE


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Anastomotic Leak


subject: UNII:D3IAG45DAK

subject_name: netakimab

object_name: Chronic small plaque psoriasis


subject: UMLS:C5448040


subject: CHEBI:44915

subject_name: Propofol

object_name: brain cancer


subject: CHEBI:8802

subject_name: Remifentanil


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: Uses contraception (finding)


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: chronic neck pain


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: chronic pain (diagnosis)


subject: CHEBI:26710

object_name: Chronic pain


subject: CHEBI:29958

subject_name: L-aspartic acid residue

object_name: type 2 diabetes mellitus


subject: CHEBI:22660

subject_name: aspartic acid


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Overweight


subject: CHEBI:64356

subject_name: Pregabalin

object_name: arthroplasty; complications


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Chronic graft versus host disease oral


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: Bacterial endophthalmitis


subject: PUBCHEM.COMPOUND:3467

object_name: endophthalmitis


subject: PUBCHEM.COMPOUND:3467

object_name: Endophthalmitis, CTCAE


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:3745


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Radiculopathy, Cervical


subject: PUBCHEM.COMPOUND:23667621

object_name: Cervical spondylosis without myelopathy


subject: PUBCHEM.COMPOUND:23667621

object_name: Neck Arthritis


subject: PUBCHEM.COMPOUND:23667621

object_name: Epiphysiolysis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:74790

subject_name: Pro-Ile

object_name: HIV infection


subject: CHEBI:53806

subject_name: phenyl isocyanate


subject: CHEBI:35780

subject_name: phosphate ion


subject: CHEBI:28874

subject_name: phosphatidylinositol


subject: CHEBI:61484

subject_name: polyimide polymer


subject: PR:000014678


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: urothelial carcinoma


subject: CHEBI:73604

object_name: transitional cell carcinoma


subject: UMLS:C5197457

object_name: heart disorder


subject: UMLS:C5204520

object_name: Hodgkin Disease


subject: UNII:40AX66P76P

subject_name: ATRACURIUM BESYLATE

object_name: Inguinal hernia


subject: UNII:40AX66P76P

object_name: Post-Operative Pain


subject: CHEBI:2914

subject_name: Atracurium


subject: CHEBI:2914


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:5280

subject_name: Gatifloxacin


subject: CHEBI:5280


subject: UMLS:C1258065

subject_name: Zymar


subject: UMLS:C1258065


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: Dry Eye, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108661

object_name: Dryness of eye


subject: UMLS:C5417975

subject_name: Anti-CD47 ADC SGN-CD47M

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417975

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5417975

object_name: non-small cell lung carcinoma


subject: UMLS:C5417975

object_name: colorectal cancer


subject: UMLS:C5417975

object_name: colorectal carcinoma


subject: UMLS:C5417975

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5417975

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5417975

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5417975

object_name: sarcoma


subject: UMLS:C5417975

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5417975

object_name: soft tissue sarcoma


subject: UMLS:C5417975

object_name: Stomach cancer


subject: UMLS:C5417975

object_name: ovarian cancer


subject: UMLS:C5417975

object_name: ovarian carcinoma


subject: UMLS:C5417975

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5417975

object_name: breast carcinoma


subject: UMLS:C5417975

object_name: melanoma


subject: CHEBI:8888

subject_name: Ropinirole

object_name: Unverricht-Lundborg syndrome


subject: CHEBI:58097

object_name: Head Injury


subject: CHEBI:58097

object_name: Closed head injuries


subject: CHEBI:58097

object_name: Control of Closed head injuries


subject: CHEBI:58097

object_name: subarachnoid hemorrhage


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:9434

subject_name: Telmisartan

object_name: neuralgia


subject: CHEBI:9434

object_name: Neuropathic pain


subject: CHEBI:9434

object_name: Effects of chemotherapy


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: lung sarcomatoid carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: neoplasm of thorax


subject: UNII:2S9ZZM9Q9V

object_name: lung disorder


subject: CHEBI:31355

subject_name: Carboplatin


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEBI:95165

object_name: Acute myeloid leukemia in remission


subject: CHEBI:50131

subject_name: Decitabine


subject: UNII:349552KRHK

subject_name: Simendan

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:349552KRHK

object_name: amyotrophic lateral sclerosis


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: PUBCHEM.COMPOUND:162623518

subject_name: GLOBALAGLIATIN HYDROCHLORIDE

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:162623518

object_name: diabetic hyperglycaemia


subject: UNII:CH9BD8J28R


subject: UNII:CH9BD8J28R


subject: PR:000013730

subject_name: Rap guanine nucleotide exchange factor 5

object_name: Sickle cell nephropathy


subject: PR:000013730

object_name: acute chest syndrome


subject: PR:000013730

object_name: Vaso-Occlusive Crisis


subject: PR:000013730

object_name: sickle cell disease


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Guillain-Barre syndrome


subject: UNII:A3ULP0F556

object_name: Guillain-Barre Syndrome, CTCAE


subject: UMLS:C1815825

subject_name: NIGELLA Extract

object_name: Acute respiratory distress syndrome due to COVID-19


subject: PUBCHEM.COMPOUND:2269

object_name: Crohn disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: dermatitis


subject: PUBCHEM.COMPOUND:44602504

object_name: Eczema, CTCAE


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: acquired polycythemia vera


subject: CHEBI:9123

subject_name: Sertraline

object_name: Adverse drug response


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Small cell lung cancer extensive stage


subject: UNII:Q8MI0X869M

object_name: neoplasm


subject: UMLS:C5548521

subject_name: Idebenone 150 mg oral tablet

object_name: Leber hereditary optic neuropathy


subject: UMLS:C4086231

object_name: cervical cancer


subject: UMLS:C4086231

object_name: cervical carcinoma


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: Drug action (disorder)


subject: CHEBI:177512

subject_name: Sagopilone

object_name: ovarian cancer


subject: CHEBI:177512

object_name: ovarian neoplasm


subject: UNII:T5RCK09KHV

subject_name: Fipamezole

object_name: multiple system atrophy


subject: UNII:T5RCK09KHV

object_name: Parkinson disease


subject: CHEBI:9123

object_name: Cryptococcal infections


subject: CHEBI:9123

object_name: cryptococcosis


subject: CHEBI:9123

object_name: AIDS-Related Opportunistic Infections


subject: CHEBI:8988

object_name: brain glioma


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Pancreatic adenocarcinoma resectable


subject: CHEBI:30496

subject_name: Sulfur hexafluoride

object_name: carotid stenosis


subject: CHEBI:135967

subject_name: Casopitant

object_name: Depressed mood


subject: CHEBI:135967

object_name: Cancer patients and suicide and depression


subject: CHEBI:135967

object_name: Depressed - symptom


subject: CHEBI:135967

object_name: Depression, CTCAE


subject: CHEBI:135967

object_name: fibromyalgia


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: sickle cell disease


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: Advanced breast cancer


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:57858

subject_name: atropinium

object_name: Respiratory arrest


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: CHEBI:6801

subject_name: Metformin

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:6801

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: pancreatic adenocarcinoma


subject: PR:000014143

subject_name: ribonuclease inhibitor

object_name: differentiated thyroid carcinoma


subject: PR:000013111

subject_name: RelA-associated inhibitor


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Menorrhagia


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:6121

subject_name: Ketamine

object_name: Recurrent depressive disorder


subject: CHEBI:6121

object_name: Recurrent disease


subject: CHEBI:6121

object_name: Global Relapse in Viscera


subject: CHEBI:6121

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:6121

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:6121

object_name: Global Relapse


subject: CHEBI:6121

object_name: Global Relapse in Skin


subject: CHEBI:6121

object_name: Global Relapse in Blood


subject: UNII:G1G66XE93W


subject: UNII:G1G66XE93W

object_name: metastatic neoplasm


subject: UNII:G1G66XE93W

object_name: Embolism, Tumor


subject: UNII:G1G66XE93W

object_name: Neoplasm Metastasis


subject: UNII:G1G66XE93W

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:135449332

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:135449332

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:135449332

object_name: follicular lymphoma


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:3423

subject_name: Carmustine

object_name: Metastatic Uveal Melanoma


subject: CHEBI:3423

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:3423

object_name: Stage IV Choroidal and Ciliary Body Melanoma AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL1201458

subject_name: ETHIODIZED OIL


subject: CHEMBL.COMPOUND:CHEMBL1201458


subject: CHEMBL.COMPOUND:CHEMBL1201458


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Becker disease


subject: CHEBI:6367

object_name: Thomsen disease


subject: CHEBI:6367

object_name: Thomsen and Becker disease


subject: CHEBI:6367

object_name: paramyotonia congenita of Von Eulenburg


subject: CHEBI:6367

object_name: potassium-aggravated myotonia


subject: CHEBI:6367

object_name: myotonic dystrophy type 1


subject: CHEBI:6367

object_name: hyperkalemic periodic paralysis


subject: PUBCHEM.COMPOUND:139596280

subject_name: Pegvaliase

object_name: classic phenylketonuria


subject: UNII:9NKZ9LYZ06

subject_name: cenderitide

object_name: kidney failure


subject: CHEMBL.COMPOUND:CHEMBL2108721

subject_name: CENDERITIDE


subject: UMLS:C4058551

subject_name: Paliperidone ER

object_name: insomnia


subject: UMLS:C4058551

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C4058551

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Laceration


subject: UMLS:C4727058

subject_name: Lipustobart

object_name: Childhood Solid Neoplasm


subject: UMLS:C4727058

object_name: Adult Solid Neoplasm


subject: UMLS:C4727058

object_name: Solid Neoplasm


subject: CHEBI:17688

subject_name: Nicotine

object_name: substance-related disorder


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch


subject: UNII:JUP57A8EPZ

object_name: Childhood Breast Carcinoma


subject: UNII:JUP57A8EPZ

object_name: breast carcinoma


subject: UNII:JUP57A8EPZ

object_name: breast cancer


subject: DRUGBANK:DB19218

subject_name: Camizestrant


subject: DRUGBANK:DB19218


subject: DRUGBANK:DB19218


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: intracranial hypertension


subject: CHEBI:140621

object_name: traumatic encephalopathy


subject: CHEBI:140621

object_name: traumatic brain injury


subject: UMLS:C3827074

object_name: Oral Mucositis


subject: UMLS:C3827074

object_name: stomatitis


subject: UMLS:C3827074

object_name: oral mucositis


subject: UNII:O519NVW73R

subject_name: Capadenoson

object_name: Angina pectoris


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: pharynx cancer


subject: UNII:PQX0D8J21J

object_name: carcinoma of pharynx


subject: UNII:PQX0D8J21J

object_name: paranasal sinus neoplasm


subject: UNII:PQX0D8J21J

object_name: Nose Neoplasms


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: laryngeal carcinoma


subject: CHEBI:44423

object_name: larynx cancer


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:42944

subject_name: Galantamine

object_name: Cognitive impairment


subject: UMLS:C3256144

subject_name: Copaifera officinalis resin

object_name: head and neck neoplasm


subject: UMLS:C3256144


subject: UMLS:C3256144

object_name: Mucositis Oral, CTCAE


subject: UMLS:C3256144

object_name: Disorder due to radiotherapy


subject: CHEBI:4315

subject_name: Danazol

object_name: Fanconi anemia


subject: CHEBI:4315

object_name: Fanconi anemia complementation group A


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Shock


subject: CHEBI:75722

subject_name: Tramadol

object_name: Platelet dysfunction


subject: CHEBI:75722

object_name: blood coagulation disease


subject: CHEBI:75722

object_name: Drug toxicity


subject: PUBCHEM.COMPOUND:16051941

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: chronic eosinophilic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:1805

object_name: cellular phase chronic idiopathic myelofibrosis


subject: PUBCHEM.COMPOUND:1805

object_name: Overt Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:1805

object_name: essential thrombocythemia


subject: PUBCHEM.COMPOUND:1805

object_name: acquired polycythemia vera


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:93776

object_name: myeloid neoplasm


subject: CHEBI:93776

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:93776

object_name: chronic neutrophilic leukemia


subject: CHEBI:93776


subject: CHEBI:93776

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:93776

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:93776

object_name: myeloproliferative neoplasm


subject: CHEBI:93776

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:93776


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:6121

subject_name: Ketamine

object_name: Headache


subject: CHEBI:6121

object_name: Headache, CTCAE


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: cardiotoxicity


subject: UMLS:C5400115

object_name: kidney disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:230076

subject_name: Aureolic acid

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:230076

object_name: sarcoma


subject: PUBCHEM.COMPOUND:230076

object_name: Ewing sarcoma


subject: CHEBI:31856

subject_name: Plicamycin


subject: CHEBI:31856


subject: CHEBI:31856


subject: MESH:D002214

subject_name: Capsules

object_name: iron deficiency anemia


subject: MESH:D002214

object_name: Anemia of pregnancy


subject: UMLS:C5203356

subject_name: Tocilizumab Liquid Injection

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C2959259

subject_name: Injection, tocilizumab, 1 mg administered


subject: KEGG.COMPOUND:C02380

object_name: B-Cell Leukemia


subject: KEGG.COMPOUND:C02380

object_name: non-Hodgkin lymphoma


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:52717

subject_name: Bortezomib

object_name: T-cell leukemia


subject: CHEBI:52717


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:63612

subject_name: Nelarabine


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:85990

subject_name: Panobinostat

object_name: acute lymphoblastic leukemia


subject: CHEBI:85990


subject: CHEBI:85990


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: bronchiectasis


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: PUBCHEM.COMPOUND:66580799

subject_name: Roginolisib

object_name: ocular melanoma


subject: PUBCHEM.COMPOUND:66580799

object_name: uveal melanoma


subject: UNII:6K8FC2TF54

subject_name: ROGINOLISIB


subject: UNII:6K8FC2TF54


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: ovarian cancer


subject: CHEBI:46195

object_name: ovarian neoplasm


subject: CHEBI:46195

object_name: ovarian carcinoma


subject: CHEBI:46195

object_name: fallopian tube carcinoma


subject: CHEBI:46195

object_name: fallopian tube cancer


subject: CHEBI:46195

object_name: primary peritoneal carcinoma


subject: CHEBI:46195

object_name: Primary Peritoneal Cancer


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: UMLS:C2919009

subject_name: Histamine-1 Receptor Inhibitor [EPC]


subject: UMLS:C2919009


subject: UMLS:C2919009


subject: UMLS:C2919009


subject: UMLS:C2919009


subject: UMLS:C2919009


subject: UMLS:C2919009


subject: UMLS:C3536871

subject_name: Histamine-1 Receptor Antagonist [EPC]


subject: UMLS:C3536871


subject: UMLS:C3536871


subject: UMLS:C3536871


subject: UMLS:C3536871


subject: UMLS:C3536871


subject: UMLS:C3536871


subject: UMLS:C0019593

subject_name: Histamine H2 Antagonists


subject: UMLS:C0019593


subject: UMLS:C0019593


subject: UMLS:C0019593


subject: UMLS:C0019593


subject: UMLS:C0019593


subject: UMLS:C0019593


subject: UMLS:C3536872

subject_name: Histamine-2 Receptor Antagonist [EPC]


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Recurrent ovarian cancer


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron


subject: UNII:CMJ4GT6MRD

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Dry Eye, CTCAE


subject: CHEBI:201431

object_name: Dryness of eye


subject: CHEBI:6427

subject_name: Leuprolide

object_name: mild neurocognitive disorder


subject: CHEBI:6427

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:134823896

subject_name: SERDEXMETHYLPHENIDATE

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:134823896


subject: CHEBI:78739

subject_name: Emodepside

object_name: ancylostomiasis


subject: CHEBI:78739

object_name: ascariasis


subject: CHEBI:78739

object_name: Infection by Ascaris lumbricoides


subject: UMLS:C1098962


subject: UMLS:C1098962


subject: UMLS:C1098962


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: intestinal obstruction


subject: CHEBI:8382

subject_name: Prednisone

object_name: infertility


subject: CHEBI:8382

object_name: autoimmune thyroid disease


subject: CHEBI:15365

subject_name: Aspirin


subject: UMLS:C5782152

subject_name: Tyrosine Kinase 2 Inhibitor [EPC]

object_name: Chronic small plaque psoriasis


subject: CHEBI:44915

subject_name: Propofol

object_name: cognitive disorder


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:49900

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: MESH:C000719587

object_name: Chronic pelvic pain syndrome


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Advanced Melanoma


subject: PR:000005931


subject: UMLS:C0534628

subject_name: Endostatins


subject: UMLS:C1705207

subject_name: Endostar


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UNII:1C6V77QF41

object_name: vitiligo


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:86474

object_name: non-small cell squamous lung carcinoma


subject: PUBCHEM.COMPOUND:11351859


subject: UMLS:C2742210


subject: CHEBI:73666

subject_name: Thr-Trp

object_name: membranous glomerulonephritis


subject: PUBCHEM.COMPOUND:160187828

object_name: Parkinson disease


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: acute myeloid leukemia with BCR-ABL1


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:PVI5M0M1GW

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: leukemia, myeloid, accelerated-phase


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674

object_name: Blast Phase


subject: UNII:3A58010674


subject: CHEBI:78543

subject_name: Ponatinib


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: myocardial infarction


subject: DRUGBANK:DB14744

object_name: diabetes mellitus


subject: DRUGBANK:DB14744

object_name: Albuminuria


subject: DRUGBANK:DB14744

object_name: stroke disorder


subject: DRUGBANK:DB14744

object_name: cerebrovascular disorder


subject: DRUGBANK:DB14744

object_name: Stroke (heart beat)


subject: DRUGBANK:DB14744

object_name: Stroke, CTCAE


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Depressed mood


subject: CHEBI:5494

object_name: Cancer patients and suicide and depression


subject: CHEBI:5494

object_name: Depressed - symptom


subject: CHEBI:5494

object_name: Depression, CTCAE


subject: CHEBI:5494

object_name: Hyperhidrosis


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:8707

subject_name: Quetiapine


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Weight loss


subject: PUBCHEM.COMPOUND:46783403

object_name: Weight Loss, CTCAE


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Loss of INI 1 Protein Expression


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: hypertension


subject: UMLS:C0728976

object_name: Hypertension, CTCAE


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: CHEBI:77319

subject_name: Oltipraz

object_name: Liver Fibrosis


subject: CHEBI:77319

object_name: liver cirrhosis


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Colorectal cancer stage IV


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UMLS:C4331912


subject: GTOPDB:8313

subject_name: talazoparib

object_name: neuroendocrine neoplasm


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Malignant neoplasm of abdomen


subject: CHEBI:6456

object_name: Pelvic Cancer


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:5062

subject_name: Finasteride

object_name: Prostate Pain, CTCAE 3.0


subject: CHEBI:5062

object_name: Prostatic Pain


subject: CHEBI:5062

object_name: prostate disorder


subject: CHEBI:5062

object_name: lower urinary tract symptom


subject: CHEBI:5062

object_name: urinary tract obstruction


subject: CHEBI:5062

object_name: urinary system disorder


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: nonobstructive coronary artery disease


subject: CHEBI:28939

object_name: Nonocclusive coronary artery atherosclerosis


subject: CHEBI:28939

object_name: Angina attack


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: type 2 diabetes mellitus


subject: CHEBI:2904

subject_name: Atenolol


subject: UMLS:C1509547

subject_name: Rice Preparation

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1509547

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C1509547

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C3484401

subject_name: brown rice preparation


subject: UMLS:C3484401


subject: UMLS:C3484401


subject: DRUGBANK:DB10563

subject_name: Rice


subject: DRUGBANK:DB10563


subject: DRUGBANK:DB10563


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hallux valgus


subject: CHEBI:3215

object_name: Hallux rigidus


subject: UNII:2S9ZZM9Q9V

object_name: keloid


subject: CHEBI:57694

object_name: Flushing


subject: CHEBI:57694

object_name: Flushing, CTCAE 5.0


subject: CHEBI:57694

object_name: Flushing, CTCAE 3.0


subject: CHEBI:57694

object_name: Erythema


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:45783

subject_name: Imatinib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:681569

subject_name: Clofarabine

object_name: inflammatory bowel disease 1


subject: CHEBI:681569

object_name: Crohn disease


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:139600317

object_name: glioma


subject: PUBCHEM.COMPOUND:139600317

object_name: malignant glioma


subject: UMLS:C5700409


subject: UMLS:C5700409


subject: UMLS:C4528767

subject_name: Gleolan

object_name: Adult Meningioma


subject: UMLS:C4528767

object_name: benign meningioma


subject: UMLS:C4528767

object_name: familial meningioma


subject: UMLS:C4528767

object_name: pediatric meningioma


subject: UMLS:C4528767

object_name: meningioma


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:27432


subject: CHEBI:27432


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: CHEBI:16977


subject: CHEBI:16977


subject: CHEBI:16977


subject: UNII:O4BT6C02M2

subject_name: Zetomipzomib

object_name: adult dermatomyositis


subject: UNII:O4BT6C02M2

object_name: dermatomyositis


subject: UNII:O4BT6C02M2

object_name: polymyositis


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: bacterial pleural effusion other than tuberculosis


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: CHEBI:90844

subject_name: Selexipag

object_name: Buerger Disease


subject: UNII:G6UF363ECX

object_name: Clear-cell metastatic renal cell carcinoma


subject: UMLS:C4308025

subject_name: AAA 617


subject: UNII:XKW9MYF94Y

object_name: benign prostatic hyperplasia


subject: CHEBI:52763


subject: UNII:9GJ8S4GU0M

subject_name: Mipomersen

object_name: arteriosclerosis disorder


subject: UNII:9GJ8S4GU0M

object_name: atherosclerosis


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: Recurrent urinary tract infections


subject: UMLS:C2267235

subject_name: Vitamin K Antagonist [EPC]

object_name: acute coronary syndrome


subject: UMLS:C3653316

subject_name: Vitamin K antagonists


subject: UMLS:C3275195

subject_name: Celsentri

object_name: HIV infection


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Melanoma recurrent


subject: CHEBI:72317

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:72317

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:541197

object_name: Menopause


subject: CHEBI:7627

subject_name: Norethisterone


subject: CHEBI:7627


subject: PUBCHEM.COMPOUND:5487426

subject_name: Tiotropium bromide

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:32230

subject_name: tiotropium bromide hydrate


subject: CHEMBL.COMPOUND:CHEMBL1182657

subject_name: tiotropium bromide


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UNII:PQX0D8J21J

object_name: Head and Neck Basaloid Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: Neck Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: head and neck neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Head and Neck Basaloid Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: oropharyngeal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: oropharynx cancer


subject: UMLS:C2703138

subject_name: ficlatuzumab

object_name: Neck Carcinoma


subject: UMLS:C2703138

object_name: head and neck neoplasm


subject: UMLS:C2703138

object_name: head and neck cancer


subject: UMLS:C2703138

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2703138

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C2703138

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2703138

object_name: Head and Neck Basaloid Squamous Cell Carcinoma


subject: UMLS:C2703138

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2703138

object_name: Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2703138

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2703138

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2703138

object_name: oropharyngeal carcinoma


subject: UMLS:C2703138

object_name: oropharynx cancer


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: nephrocalcinosis


subject: UMLS:C1541366

subject_name: Allogeneic GM-CSF-Secreting Breast Cancer Vaccine

object_name: breast neoplasm


subject: CHEBI:28364

subject_name: Icosapent

object_name: classic familial adenomatous polyposis


subject: CHEBI:28364

object_name: Adenomatous colonic polyposis


subject: UMLS:C5139693

subject_name: Pegbelfermin

object_name: liver cirrhosis


subject: UMLS:C5139942


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Legally induced abortion, without mention of complication, unspecified


subject: UMLS:C4705566

object_name: sciatica


subject: RXCUI:1597094

subject_name: 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection

object_name: Vulval intraepithelial neoplasia grade 2


subject: RXCUI:1597094

object_name: human papilloma virus infection


subject: RXCUI:1597101

subject_name: 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe


subject: RXCUI:1597101


subject: UMLS:C4085973

object_name: Metastatic human epidermal growth factor 2 positive carcinoma of breast


subject: CHEBI:84739

object_name: Sepsis


subject: CHEBI:84739

object_name: Sepsis, CTCAE


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:2637


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib

object_name: endometrium adenocarcinoma


subject: UNII:ZXM835LQ5E

object_name: endometrial clear cell adenocarcinoma


subject: UNII:ZXM835LQ5E

object_name: endometrial serous adenocarcinoma


subject: UNII:ZXM835LQ5E

object_name: endometrial mixed adenocarcinoma


subject: UNII:ZXM835LQ5E

object_name: Recurrent Uterine Corpus Cancer


subject: UNII:ZXM835LQ5E

object_name: endometrial undifferentiated carcinoma


subject: UNII:ZXM835LQ5E

object_name: undifferentiated carcinoma of the corpus uteri


subject: UMLS:C3896812

object_name: Advanced cancer


subject: UMLS:C3154258

subject_name: Gamunex-C


subject: UNII:KXC7811DBY

subject_name: ACOLBIFENE HYDROCHLORIDE

object_name: Childhood Breast Carcinoma


subject: UNII:KXC7811DBY

object_name: breast cancer


subject: UMLS:C1879543

subject_name: Acolbifene Hydrochloride


subject: UMLS:C1879543


subject: CHEBI:4910

subject_name: Etomidate

object_name: adrenocortical insufficiency


subject: CHEBI:4910

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:45652

subject_name: Succinylcholine


subject: CHEBI:45652


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: adult lymphoma


subject: CHEBI:44423

object_name: lymphoma


subject: CHEBI:44423

object_name: pediatric lymphoma


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: histoplasmosis retinitis


subject: MESH:D006496

subject_name: Heparinoids

object_name: Skin Bruise


subject: MESH:D006496

object_name: Easy Bruising


subject: MESH:D006496

object_name: Ecchymosis


subject: MESH:D006496

object_name: Periorbital Edema, CTCAE


subject: MESH:D006496

object_name: Periorbital edema


subject: MESH:D006496

object_name: Cryotherapy effect


subject: MESH:D006496

object_name: nervous system disorder


subject: MESH:D006496

object_name: Caries of infancy associated with breastfeeding


subject: CHEBI:63633

subject_name: Triptorelin

object_name: cancer


subject: CHEBI:63633

object_name: neoplasm


subject: CHEBI:63633

object_name: Toxicity due to chemotherapy


subject: CHEBI:63633

object_name: Ewing sarcoma


subject: CHEBI:63633

object_name: pediatric osteosarcoma


subject: CHEBI:63633

object_name: Osteosarcoma


subject: CHEBI:63633

object_name: adult lymphoma


subject: CHEBI:63633

object_name: lymphoma


subject: CHEBI:63633

object_name: pediatric lymphoma


subject: CHEBI:63633

object_name: malignant soft tissue neoplasm


subject: CHEBI:63633

object_name: sarcoma


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: cervical cancer


subject: UMLS:C1882421

object_name: cervical carcinoma


subject: UMLS:C1882421

object_name: Cervical intraepithelial neoplasia grade 1


subject: UMLS:C1882421

object_name: human papilloma virus infection


subject: CHEBI:39867

subject_name: Valproic acid

object_name: bipolar I disorder


subject: UMLS:C0939309

subject_name: Depakote ER


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Growth delay


subject: UMLS:C2744652

object_name: skin disorder caused by infection


subject: UMLS:C2744652

object_name: skin infection


subject: UMLS:C0733688

object_name: hemophagocytic syndrome


subject: UMLS:C1095908

subject_name: legume preparation

object_name: Impaired fasting glucose


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost


subject: PUBCHEM.COMPOUND:6435378

object_name: Respiratory Failure, CTCAE


subject: PUBCHEM.COMPOUND:52940166

object_name: adult hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:52940166

object_name: liver cancer


subject: PUBCHEM.COMPOUND:52940166

object_name: pediatric hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:52940166

object_name: liver carcinoma


subject: CHEBI:25017

subject_name: leucine

object_name: type 2 diabetes mellitus


subject: UMLS:C5421405

subject_name: Vidofludimus Calcium

object_name: sclerosing cholangitis


subject: UMLS:C5421405

object_name: primary sclerosing cholangitis


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: hypertriglyceridemia


subject: CHEBI:5296

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:44369

subject_name: Duvoglustat

object_name: glycogen storage disease II


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate

object_name: Cardiovascular event


subject: CHEBI:45783

subject_name: Imatinib

object_name: Postmenopausal


subject: CHEBI:45783

object_name: KIT Positive


subject: CHEBI:45783

object_name: PDGFR Positive


subject: CHEBI:45783

object_name: Progesterone Receptor Positive


subject: CHEBI:45783

object_name: Estrogen Receptor Positive


subject: CHEBI:45783

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:45783

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:29998

subject_name: D-serine residue

object_name: cocaine dependence


subject: CHEBI:17115

subject_name: Serine


subject: UMLS:C1880218

subject_name: serine, D-


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: open-angle glaucoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Primary malignant neoplasm of skin of face


subject: UNII:38EAO245ZX

subject_name: Dutogliptin

object_name: ST-elevation myocardial infarction


subject: UNII:38EAO245ZX

object_name: ST Elevation Myocardial Infarction


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: facioscapulohumeral muscular dystrophy


subject: UNII:NQX9KB6PCL

object_name: facioscapulohumeral muscular dystrophy 1


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: UNII:0E3D72URPD

object_name: Atopic rhinitis


subject: UNII:0E3D72URPD

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C4733650

subject_name: Prodrug APX001

object_name: Mycoses


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Childhood Solid Neoplasm


subject: UMLS:C4086713

object_name: Adult Solid Neoplasm


subject: UMLS:C4086713

object_name: Solid Neoplasm


subject: UMLS:C4086713

object_name: endometrial cancer


subject: UMLS:C4086713

object_name: uterine corpus cancer


subject: UMLS:C4086713

object_name: endometrial carcinoma


subject: UMLS:C4086713

object_name: colorectal neoplasm


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: latent tuberculosis infection


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UNII:MW2AIJ8USP

subject_name: Elubrixin

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C5206815

object_name: esophageal squamous cell carcinoma


subject: CHEBI:177298

object_name: cervical cancer


subject: CHEBI:177298

object_name: cervical carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: UMLS:C4745334

subject_name: JAK1 Inhibitor AZD4205

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C4745334

object_name: non-small cell lung carcinoma


subject: UMLS:C4745334

object_name: lung cancer


subject: UMLS:C2608488

subject_name: quetiapine 50 MG Extended Release Oral Tablet

object_name: major depressive disorder


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Sturge-Weber syndrome


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:41879

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:41879

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:41879

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: Cat Allergy


subject: UMLS:C5227766

subject_name: AMG 157


subject: UMLS:C5204220

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:4672

subject_name: Docetaxel

object_name: skin squamous cell carcinoma


subject: CHEBI:4672

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: MESH:D007651

subject_name: Keto Acids

object_name: kidney failure


subject: MESH:D007651

object_name: Renal Failure, CTCAE


subject: UMLS:C5392086

subject_name: Superparamagnetic Iron Oxide Nanoparticles

object_name: heart aneurysm


subject: CHEBI:139547

subject_name: superparamagnetic iron oxide nanoparticle


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: cancer of unknown primary site


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: CHEBI:15365

subject_name: Aspirin

object_name: habitual spontaneous abortion


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: CHEBI:135207

subject_name: Clofedanol


subject: PR:000004321

subject_name: arylsulfatase A


subject: PUBCHEM.COMPOUND:126664

object_name: Sepsis


subject: PUBCHEM.COMPOUND:126664

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:126664

object_name: Bacterial Infections and Mycoses


subject: CHEBI:5523

subject_name: Goserelin

object_name: Breast cancer stage II


subject: CHEBI:5523

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:5523

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:5523

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:5523

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:5523

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0149473

subject_name: Zoladex

object_name: Her2-receptor negative breast cancer


subject: UMLS:C0149473

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Femur fracture


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:27953

subject_name: Physostigmine

object_name: Cognitive impairment


subject: MESH:C000730434

subject_name: TRPC inhibitor BI 1358894

object_name: major depressive disorder


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage III Colon Cancer


subject: CHEBI:231679

object_name: Stage II Colon Cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: UMLS:C2987342

object_name: Childhood Neuroblastoma


subject: UMLS:C2987342

object_name: neuroblastoma


subject: UMLS:C1709066

object_name: plasma cell myeloma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: urinary system neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:7565

subject_name: Nifedipine

object_name: pulmonary hypertension


subject: CHEBI:7565

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:5523

subject_name: Goserelin

object_name: Estrogen Receptor Positive


subject: CHEBI:5523

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:5523

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:5523

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:5523

object_name: HER2/Neu Negative


subject: CHEBI:5523

object_name: Breast cancer recurrent


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: CHEBI:195558

subject_name: Entrectinib

object_name: ROS1 gene rearrangement


subject: CHEBI:63632

subject_name: Topotecan

object_name: cancer of unknown primary site


subject: CHEBI:6801

subject_name: Metformin

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: focal segmental glomerulosclerosis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: spina bifida


subject: PUBCHEM.COMPOUND:86217377

object_name: Spina bifida without mention of hydrocephalus, site unspecified


subject: PUBCHEM.COMPOUND:86217377

object_name: neural tube defects, susceptibility to


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: CHEBI:144551


subject: UMLS:C0796493

subject_name: Docetaxel/Gemcitabine

object_name: Metastatic Ewing's Sarcoma


subject: UMLS:C0796493

object_name: Metastatic osteosarcoma


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: sclerosing cholangitis


subject: UNII:9RV78Q2002

object_name: primary sclerosing cholangitis


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: acute liver failure


subject: CHEBI:46195

object_name: liver failure


subject: CHEBI:233364

subject_name: Bryostatin

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: UMLS:C2830067

object_name: Childhood Breast Carcinoma


subject: UMLS:C2830067

object_name: breast carcinoma


subject: UMLS:C2830067

object_name: breast cancer


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat


subject: PUBCHEM.COMPOUND:11670360


subject: PUBCHEM.COMPOUND:11670360


subject: UMLS:C4733699

subject_name: cafusertib hydrochloride

object_name: acute myeloid leukemia


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Cannabis use disorder


subject: UMLS:C1384659

object_name: prostate carcinoma


subject: UMLS:C1384659

object_name: prostate cancer


subject: UMLS:C4287686

subject_name: Factor VII-targeting Immunoconjugate Protein ICON-1

object_name: uveal melanoma


subject: UMLS:C4287686

object_name: choroid neoplasm


subject: UMLS:C4287686

object_name: choroid cancer


subject: PUBCHEM.COMPOUND:64987

object_name: Pregnant


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:4702

subject_name: Dorzolamide

object_name: diabetic retinopathy


subject: CHEBI:63925

subject_name: PhXa 85


subject: PUBCHEM.COMPOUND:152165


subject: CHEBI:47381

subject_name: Diclofenac


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Wrinkled structure


subject: UMLS:C0013227

object_name: Skin Wrinkling


subject: UMLS:C0013227

object_name: Solar elastosis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Prostate cancer recurrent


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: Adult Solid Neoplasm


subject: CHEBI:7496


subject: CHEBI:187893

subject_name: Baclofen

object_name: spastic diplegia


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Vomiting, CTCAE


subject: CHEBI:6950

object_name: Vomiting


subject: CHEBI:6950

object_name: Nausea, CTCAE_5


subject: CHEBI:6950

object_name: Nausea


subject: CHEBI:6950

object_name: Nausea, CTCAE_3


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: MESH:C571759

subject_name: R-CHOP protocol

object_name: high grade B-cell lymphoma


subject: MESH:C571759

object_name: ALK-positive anaplastic large cell lymphoma


subject: MESH:C571759

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: MESH:C571759

object_name: grade 3B follicular lymphoma


subject: GTOPDB:12989

subject_name: toripalimab

object_name: diffuse large B-cell lymphoma


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: carcinoma


subject: UMLS:C1530450

subject_name: AMG 162